Association between clusterin gene polymorphism rs11136000 and late‑onset Alzheimer's disease susceptibility: A review and meta‑analysis of case‑control studies

Du,Wenjin; Tan,Jiping; Xu,Wei; Chen,Jinwen; Wang,Luning

doi:10.3892/etm.2016.3734

Association between clusterin gene polymorphism rs11136000 and late‑onset Alzheimer's disease susceptibility: A review and meta‑analysis of case‑control studies

Authors:
- Wenjin Du
- Jiping Tan
- Wei Xu
- Jinwen Chen
- Luning Wang
View Affiliations

Affiliations: Department of Geriatric Neurology, Chinese PLA General Hospital of the Air Force, Beijing 100142, P.R. China, Department of Geriatric Neurology, Clinical Division of South Building, Chinese PLA General Hospital, Beijing 100853, P.R. China
Published online on: September 21, 2016 https://doi.org/10.3892/etm.2016.3734
Pages: 2915-2927
Copyright: © Du et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to evaluate the association between rs11136000 in clusterin (CLU) and late‑onset Alzheimer's disease (LOAD) by meta‑analysis. Several databases including PubMed, EMbase, CBMdisc and CMCC were searched for relevant case‑control studies based on defined selection criteria. Odds ratios (OR) and 95% confidence interval (CI) of the rs11136000 genotype and allele distribution were analyzed with RevMan and Stata software. The control population and heterogeneity between populations were examined in the selected studies using the Hardy‑Weinberg equilibrium. Overall OR among the frequencies of the genotype and allele in both patients with AD and controls was estimated using fixed or random effect models. The summary of the OR and 95% CI were then analyzed to obtain the effects across the studies. Publication bias was examined using a funnel plot, Egger's test and Begg's test, and a Fail‑safe Number (Nfs). A total of 20 reports were used. The summary OR for studies in the Caucasian population with a frequency of TT+TC/CC genotype and T/C allele at rs11136000 locus in CLU were 0.79 (95% CI, 0.73‑0.86; P<0.00001) and 0.87 (95% CI, 0.85‑0.90; P<0.00001). The summary OR for the studies conducted in the Asian population were 0.90 (95% CI, 0.81‑0.99; P=0.04) and 0.87 (95% CI, 0.81‑0.93; P<0.0001). The summary OR in other mixed ethnic groups with regards to the frequency of T/C allele was 0.82 (95% CI, 0.68‑0.99; P=0.04). These results demonstrated the presence of a statistically significant difference in LOAD susceptibility between individuals with the T allele CLU rs11136000 polymorphism and those without. The studies conducted in populations of African descent or Hispanics showed no statistically significant difference. Negligible publication bias was present, with Nfs being 750.604. In summary, polymorphism rs11136000 in the CLU gene may contribute to susceptibility to LOAD, and the presence of the T allele may reduce the risk of LOAD in Caucasian and Asian populations. However, no definitive association was found between the presence of the CLU rs11136000 polymorphism and LOAD in populations of African or Hispanic descent.

View Figures

View References

1	Ossenkoppele R, van der Flier WM, Zwan MD, Adriaanse SF, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P and van Berckel BN: Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology. 80:359–365. 2013. View Article : Google Scholar : PubMed/NCBI
2	Tycko B, Feng L, Nguyen L, Francis A, Hays A, Chung WY, Tang MX, Stern Y, Sahota A, Hendrie H and Mayeux R: Polymorphisms in the human apolipoprotein-J/clusterin gene: Ethnic variation and distribution in Alzheimer's disease. Hum Genet. 98:430–436. 1996. View Article : Google Scholar : PubMed/NCBI
3	Bertram L and Tanzi RE: Alzheimer's disease: New light on an old CLU. Nat Rev Neurol. 6:11–13. 2010. View Article : Google Scholar : PubMed/NCBI
4	Malkki H: Alzheimer disease: Chaperone protein clusterin is involved in amyloid-β-associated entorhinal atrophy in early AD. Nat Rev Neurol. 10:602014. View Article : Google Scholar
5	Nuutinen T, Suuronen T, Kauppinen A and Salminen A: Clusterin: A forgotten player in Alzheimer's disease. Brain Res Rev. 61:89–104. 2009. View Article : Google Scholar : PubMed/NCBI
6	Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, et al: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 41:1094–1099. 2009. View Article : Google Scholar : PubMed/NCBI
7	Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, et al: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 41:1088–1093. 2009. View Article : Google Scholar : PubMed/NCBI
8	Butler AW, Ng MY, Hamshere ML, Forabosco P, Wroe R, Al-Chalabi A, Lewis CM and Powell JF: Meta-analysis of linkage studies for Alzheimer's disease-a web resource. Neurobiol Aging. 30:1037–1047. 2009. View Article : Google Scholar : PubMed/NCBI
9	Giedraitis V, Kilander L, Degerman-Gunnarsson M, Sundelöf J, Axelsson T, Syvänen AC, Lannfelt L and Glaser A: Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men. Dement Geriatr Cogn Disord. 27:59–68. 2009. View Article : Google Scholar : PubMed/NCBI
10	Golenkina SA, Gol'tsov AIu, Kuznetsova IL, Grigorenko AP, Andreeva TV, Reshetov DA, Kunizheva SS, Shagam LI, Morozova IIu, Goldenkova-Pavlova IV, et al: Analysis of clustering gene (CLU/APOJ) polymorphism in Alzheimer's disease patients and in normal cohorts from Russian populations. Mol Biol (Mosk). 44:620–626. 2010.(In Russian). View Article : Google Scholar : PubMed/NCBI
11	Gu H, Wei X, Chen S, Kurz A, Müller U, Gasser T, Dodel RC, Farlow MR and Du Y: Association of clusterin gene polymorphisms with late-onset Alzheimer's disease. Dement Geriatr Cogn Disord. 32:198–201. 2011. View Article : Google Scholar : PubMed/NCBI
12	Bettens K, Brouwers N, Engelborghs S, Lambert JC, Rogaeva E, Vandenberghe R, Le Bastard N, Pasquier F, Vermeulen S, Van Dongen J, et al: Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased AD risk. Mol Neurodegener. 7:32012. View Article : Google Scholar : PubMed/NCBI
13	Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Dickson DW, Graff-Radford NR, et al: Replication of CLU, CR1 and PICALM associations with alzheimer's disease. Arch Neurol. 67:961–964. 2010. View Article : Google Scholar : PubMed/NCBI
14	Carrasquillo MM, Khan Qu, Murray ME, Krishnan S, Aakre J, Pankratz VS, Nguyen T, Ma L, Bisceglio G, Petersen RC, et al: Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD. Neurology. 82:1455–1462. 2014. View Article : Google Scholar : PubMed/NCBI
15	Chen LH, Kao PY, Fan YH, Ho DT, Chan CS, Yik PY, Ha JC, Chu LW and Song YQ: Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population. Neurobiol Aging. 33:210.e1–210.e7. 2012. View Article : Google Scholar
16	Ferrari R, Moreno JH, Minhajuddin AT, O'Bryant SE, Reisch JS, Barber RC and Momeni P: Implication of common and disease specific variants in CLU, CR1 and PICALM. Neurobiol Aging. 33:1846.e7–1846.e18. 2012. View Article : Google Scholar
17	Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, et al: Meta-analysis confirms CR1, CLU and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol. 67:1473–1484. 2010. View Article : Google Scholar : PubMed/NCBI
18	Kamboh MI, Minster RL, Demirci FY, Ganguli M, Dekosky ST, Lopez OL and Barmada MM: Association of CLU and PICALM variants with Alzheimer's disease. Neurobiol Aging. 33:518–521. 2012. View Article : Google Scholar : PubMed/NCBI
19	Lin YL, Chen SY, Lai LC, Chen JH, Yang SY, Huang YL, Chen TF, Sun Y, Wen LL, Yip PK, et al: Genetic polymorphisms of clusterin gene are associated with a decreased risk of Alzheimer's disease. Eur J Epidemiol. 27:73–75. 2012. View Article : Google Scholar
20	Ma JF, Liu LH, Zhang Y, Wang Y, Deng YL, Huang Y, Wang G, Xu W, Cui PJ, Fei QZ, et al: Association study of clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese Han population. Am J Alzheimers Dis Other Demen. 26:627–630. 2012. View Article : Google Scholar
21	Miyashita A, Koike A, Jun G, Wang LS, Takahashi S, Matsubara E, Kawarabayashi T, Shoji M, Tomita N, Arai H, et al: SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PLoS One. 8:e586182013. View Article : Google Scholar : PubMed/NCBI
22	Ohara T, Ninomiya T, Hirakawa Y, Ashikawa K, Monji A, Kiyohara Y, Kanba S and Kubo M: Association study of susceptibility genes for late-onset Alzheimer's disease in the Japanese population. Psychiatr Genet. 22:290–293. 2012. View Article : Google Scholar : PubMed/NCBI
23	Schjeide BM, Schnack C, Lambert JC, Lill CM, Kirchheiner J, Tumani H, Otto M, Tanzi RE, Lehrach H, Amouyel P, et al: The role of clusterin, complement receptor 1 and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels. Arch Gen Psychiatry. 68:207–213. 2011. View Article : Google Scholar : PubMed/NCBI
24	Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC, et al: Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 303:1832–1840. 2010. View Article : Google Scholar : PubMed/NCBI
25	Yu JT, Li L, Zhu QX, Zhang Q, Zhang W, Wu ZC, Guan J and Tan L: Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease. Clin Chim Acta. 411:1516–1519. 2010. View Article : Google Scholar : PubMed/NCBI
26	Lu SJ, Li HL, Sun YM, Liu ZJ, Yang P and Wu ZY: Clusterin variants are not associated with southern Chinese patients with Alzheimer's disease. Neurobiol Aging. 35:2656.e9–2656.e11. 2014. View Article : Google Scholar
27	McKhann G, Drachman D, Folstein M, Katzman R, Price D and Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984.34:939–944. View Article : Google Scholar : PubMed/NCBI
28	Leeb C, Eresheim C and Nimpf J: Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway. J Biol Chem. 289:4161–4172. 2014. View Article : Google Scholar : PubMed/NCBI
29	Trougakos IP: The molecular chaperone apolipoprotein J/clusterin as a sensor of oxidative stress: Implications in therapeutic approaches-a mini-review. Gerontology. 59:514–523. 2013. View Article : Google Scholar : PubMed/NCBI
30	Song HB, Jun HO and Kim JH, Yu YS, Kim KW, Min BH and Kim JH: Anti-apoptotic effect of clusterin on cisplatin-induced cell death of retinoblastoma cells. Oncol Rep. 30:2713–2718. 2013.PubMed/NCBI
31	Li X, Ma Y, Wei X, Li Y, Wu H, Zhuang J and Zhao Z: Clusterin in Alzheimer's disease: A player in the biological behavior of amyloid-beta. Neurosci Bull. 30:162–168. 2014. View Article : Google Scholar : PubMed/NCBI
32	Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM and Wilson MR: The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J. 21:2312–2322. 2007. View Article : Google Scholar : PubMed/NCBI
33	Howlett DR, Hortobágyi T and Francis PT: Clusterin associates specifically with Aβ40 in Alzheimer's disease brain tissue. Brain Pathol. 23:623–632. 2013. View Article : Google Scholar : PubMed/NCBI
34	Martin-Rehrmann MD, Hoe HS, Capuani EM and Rebeck GW: Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain. Neurotox Res. 7:231–242. 2005. View Article : Google Scholar : PubMed/NCBI
35	Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, Kowalewski T and Holtzman DM: ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted ApoE. J Biol Chem. 279:40987–40993. 2004. View Article : Google Scholar : PubMed/NCBI
36	Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, Deane R and Zlokovic BV: Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab. 27:909–918. 2007.PubMed/NCBI
37	Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y, Wahlund LO, Westman E, Kinsey A, Güntert A, et al: Association of plasma clusterin concentration with severity, pathology and progression in Alzheimer disease. Arch Gen Psychiatry. 67:739–748. 2010. View Article : Google Scholar : PubMed/NCBI
38	Jones L, Harold D and Williams J: Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease. Biochim Biophys Acta. 1801:754–761. 2010. View Article : Google Scholar : PubMed/NCBI
39	Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, et al: Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 43:436–441. 2011. View Article : Google Scholar : PubMed/NCBI
40	Yu JT, Ma XY, Wang YL, Sun L and Tan L, Hu N and Tan L: Genetic variation in Clusterin gene and Alzheimer's disease risk in Han Chinese. Neurobiol Aging. 34:1921.e17–1921.e23. 2013. View Article : Google Scholar